Rhabdomyosarcoma is the most common soft tissue sarcoma in children. A phase II clinical trial is the first to show improved outcomes in rhabdomyosarcoma in 45 years.
Breaking the ‘stalemate’ in the most common soft tissue sarcoma in children
Rhabdomyosarcoma is the most common soft tissue sarcoma in children. A phase II clinical trial is the first to show improved outcomes in rhabdomyosarcoma in 45 years.